Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective single-arm PRO study of teriflunomide in relapsing multiple sclerosis
2013-001439-34Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Primary endpoint: Global treatment satisfaction at week 48/EOT. Started Sep 2013; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2013-001439-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001439-34.